39 research outputs found

    Age-related differences in patterns of criminal activity among a large sample of polydrug injectors in Australia

    Get PDF
    Background: The relationship between age and criminal activity among drug-using populations is poorly understood. Methods: Data from 10 years of repeat cross-sectional surveys of sentinel samples of regular people who inject drugs (PWID) across Australia (n=5844) were used to explore the relationship between age and past-month drug dealing, property crime and violent crime, and past-year arrest. Descriptive statistics were used to explore the prevalence and frequency of each outcome. The relationship between age and each outcome was measured using multivariable Poisson regression with robust error variance. Results: After adjusting for confounding factors, each 5-year increase in age was associated with significant reductions in drug dealing (adjusted incidence rate ratio [AIRR]: 0.90, 95% confidence interval [CI]: 0.87–0.94), property crime (AIRR: 0.85, 95% CI: 0.82–0.89) and violent crime (AIRR: 0.77, 95% CI: 0.70–0.85). Older participants were also significantly less likely to report being arrested in the past 12 months (AIRR: 0.91, 95% CI: 0.88–0.93). Conclusions: Younger PWID are more heavily involved in criminal activity compared with their older counterparts. This study highlights the need for early intervention programmes to prevent offending behaviour becoming entrenched, as well as continued efforts to redirect young PWID away from the criminal justice system and into treatment and education programmes

    Understanding injecting drug use in contemporary Australian settings

    No full text
    Injecting drug use is an important public health issue, causing significant morbidity and mortality worldwide. The contemporary drug market setting in Australia is defined by a lower prevalence and frequency of heroin injection among regular people who inject drugs (PWID) compared with in the past, and changing patterns of polydrug use, with some evidence of increasing use of pharmaceutical opioids. Our understanding of patterns of drug use and related risk behaviours among contemporary PWID is limited by the fact that much research has captured samples of predominantly older, long-term PWID, many of whom are on opioid substitution therapy (OST) and may use drugs only infrequently. The aim of the research presented in this thesis was to generate comprehensive information about patterns of drug use and associated risk behaviours among PWID who are active in contemporary settings, including understudied populations such as younger PWID, out-of-treatment PWID and PWID from culturally and linguistically diverse backgrounds. The Melbourne Injecting Drug User Cohort Study (MIX) is a prospective cohort of 688 community-recruited regular PWID. The median age of the cohort is 27.6 years and only 35% of participants were prescribed OST at baseline. Over 70% of the cohort completed a follow-up interview at 12 months post-baseline, demonstrating that it is possible to successfully retain a cohort of community-recruited PWID. Despite the uniqueness of this cohort, patterns of drug use by MIX participants were relatively similar to those displayed by sentinel samples of older, longer-term PWID. There were few differences in injecting initiation experiences between MIX participants who initiated injecting in contemporary settings and those who initiated in earlier settings and, although this had some ongoing impact, the relationship was not strongly related to current drug use patterns. Pharmaceutical opioid use was a key component of polydrug use among MIX participants, with 20% of the cohort reporting using illicitly-obtained pharmaceutical opioids in the month preceding baseline interview. Use of pharmaceutical opioids was however not sustained over time. The relationship between age and engagement in risk behaviours was examined using 10 years of data from the Australian Illicit Drug Reporting System, a national repeat cross-sectional survey of regular PWID recruited through needle and syringe programs, drug treatment and community settings. Older age was associated with decreased likelihood of engagement in a range of injecting-related and criminogenic risk behaviours. Injecting drug use among young people of African ethnicity was examined using MIX data and an additional qualitative study. Findings showed that injecting drug use (and substance use more broadly) and mental health are emerging issues among this community. Findings from this body of research inform the provision of harm reduction services which take into the account the key populations and patterns of drug use in the contemporary setting. Priority areas for future research include further research examining pharmaceutical opioid use among PWID, studies of substance use and mental health among resettled refugee youth, research into interventions to reduce injecting-related risk behaviours among younger PWID and additional longitudinal studies of PWID with a broader geographic focus

    The use of alprazolam by people who inject drugs in Melbourne, Australia

    No full text
    Introduction and Aims. In Australia, people who inject drugs (PWID) commonly report the use of benzodiazepines (BZDs). This paper explores the emerging use of alprazolam among PWID in Melbourne, Australia. Design and Methods. This study reports on 3year

    Deportation of non-citizen military veterans: A critical analysis of implications for the right to health

    No full text
    Military personnel are commonly exposed to health-harming conditions during their service, resulting in higher rates of physical and mental health conditions compared with the general population. In an era of mass deportations, it is notable that non-citizen military veterans are not exempt from deportation. We utilised a human rights framework to conduct a critical analysis of potential health consequences of deportation for U.S. military veterans, identifying three ways in which veterans’ rights to health may be constrained through deportation. First, honourably discharged deported veterans may be denied access to free or subsidised Veterans Affairs health services to which they would likely otherwise be entitled. Second, availability of and access to healthcare may be limited for reasons including barriers to enrolling in public insurance schemes, challenges navigating unfamiliar health systems and stigma and discrimination towards deported migrants. Finally, quality of available care may be sub-optimal due to limited expertise in service-related health issues and lack of evidence-based treatment for some health conditions (e.g. substance abuse/dependence). Binational multi-sectoral efforts are necessary to ensure that the rights to health of deported military veterans are adequately protected
    corecore